Afficher la notice abrégée

dc.contributor.editorMarkman, Maurie M.
dc.date.accessioned2021-04-20T15:46:14Z
dc.date.available2021-04-20T15:46:14Z
dc.date.issued2013
dc.identifierONIX_20210420_9789535111399_1897
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/66538
dc.description.abstractIn the chapters of this excellent text, the authors have described advances in the neoadjuvant chemotherapeutic management of a number of tumor types. Based on the extensive experience with this management concept in breast cancer, several chapters are devoted to this important topic (Section 1). Section 2 deals with the administration of neoadjuvant chemotherapy in non-breast malignancies. Those who read and study the content of the chapters in this book will come away with a far greater understanding of the rationale supporting neoadjuvant chemotherapy, the existing evidence-based data regarding its use, limitations of the approach, and required future investigative efforts to learn how to optimize the benefits of this innovative management concept.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncologyen_US
dc.subject.otherOncology
dc.titleNeoadjuvant Chemotherapy
dc.title.alternativeIncreasing Relevance in Cancer Management
dc.typebook
oapen.identifier.doi10.5772/56655
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789535111399
oapen.relation.isbn9789535171546
oapen.imprintIntechOpen
oapen.pages114


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/